Adamis Pharmaceuticals Corporation
NASDAQ: ADMP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ebrahim Versi
- Employees
- 11
- Headquarters
- San Diego, United States
- IPO year
- 1995
- Market cap
- $7.3M
- Website
- https://www.adamispharmaceuticals.com
Loading ADMP…
Loading profile data…Frequently asked questions about ADMP
What does Adamis Pharmaceuticals Corporation (ADMP) do?
Adamis Pharmaceuticals Corporation is a specialized biopharmaceutical company primarily engaged in the development and commercialization of products within the United States, targeting key therapeutic domains such as allergy, opioid overdose, respiratory conditions, and inflammatory diseases. Its current product portfolio includes SYMJEPI pre-fi...
Where does ADMP trade?
Adamis Pharmaceuticals Corporation (ADMP) trades on the NASDAQ Capital Market.
What sector is ADMP in?
Adamis Pharmaceuticals Corporation (ADMP) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Adamis Pharmaceuticals Corporation?
Ebrahim Versi is the chief executive officer of Adamis Pharmaceuticals Corporation (ADMP).
Where is Adamis Pharmaceuticals Corporation headquartered?
Adamis Pharmaceuticals Corporation is headquartered in United States.
Does ADMP pay a dividend?
Adamis Pharmaceuticals Corporation (ADMP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ADMP go public?
Adamis Pharmaceuticals Corporation (ADMP) completed its initial public offering in 1995.